General Information of Drug (ID: DMD9ZHH)

Drug Name
BI-660848
Indication
Disease Entry ICD 11 Status REF
Neuropathic pain 8E43.0 Phase 1 [1]
Cross-matching ID
TTD ID
D08DVE

References

1 ClinicalTrials.gov (NCT01145014) To Investigate Safety, Tolerability, and Pharmacokinetics of Treatment With BI 660848 Rising Single Doses (From 2 mg to 600 mg) Administered as Oral Drinking Solution(Powder in Bottle).. U.S. National Institutes of Health.